News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Coric Vlad
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/10/2023 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Ltd.
Txns:
| Bought 340,908 shares
@ $22, valued at
$7.5M
Bought 113,637 shares
@ $22, valued at
$2.5M
|
|
05/05/2023 |
4
| Coric Vlad (Director) has filed a Form 4 on Revance Therapeutics, Inc.
Txns:
| Granted 589 shares
@ $0 Granted 986 options to buy
@ $33.61, valued at
$33.1k
|
|
10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 92,050 shares
@ $148.5, valued at
$13.7M
Disposed/sold 313,500 shares
@ $148.5, valued at
$46.6M
Disposed/sold 19,130 shares
@ $148.5, valued at
$2.8M
Disposed/sold 498,261 shares
@ $148.5, valued at
$74M
Disposed/sold 13,336 options to buy
@ $0 Disposed/sold 4,444 options to buy
@ $0 Disposed/sold 30,000 options to buy
@ $0 Disposed/sold 25,000 options to buy
@ $0 Disposed/sold 10,950 options to buy
@ $0 Disposed/sold 775 options to buy
@ $0 Disposed/sold 69,225 options to buy
@ $0 |
|
01/07/2022 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Paid exercise price by delivering 5,854 shares
@ $123.86, valued at
$725.1k
Paid exercise price by delivering 4,634 shares
@ $128.87, valued at
$597.2k
Exercised 12,500 options to buy
@ $0 Granted 70,000 options to buy
@ $128.87, valued at
$9M
Granted 40,000 options to buy
@ $0 Exercised 10,000 options to buy
@ $0 |
|
11/26/2021 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Paid exercise price by delivering 5,075 shares
@ $115.55, valued at
$586.4k
Exercised 10,950 options to buy
@ $0 |
|
01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2019 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 87,500 options to buy
@ $57.4, valued at
$5M
Granted 43,800 options to buy
@ $0 |
|
06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/14/2019 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 26,007 shares
@ $50.15, valued at
$1.3M
Sold 25,955 shares
@ $50.15, valued at
$1.3M
Sold 7,883 shares
@ $50.02, valued at
$394.3k
Sold 8,262 shares
@ $50.02, valued at
$413.3k
Sold 16,110 shares
@ $50.02, valued at
$805.8k
Sold 15,783 shares
@ $50.03, valued at
$789.6k
|
|
06/01/2018 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 741 shares
@ $35, valued at
$25.9k
Sold 800 shares
@ $35, valued at
$28k
Sold 15,648 shares
@ $35.01, valued at
$547.8k
Sold 18,971 shares
@ $35.01, valued at
$664.2k
Sold 8,611 shares
@ $35.04, valued at
$301.7k
Sold 5,229 shares
@ $35.04, valued at
$183.2k
|
|
12/11/2017 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 200,000 options to buy
@ $20.79, valued at
$4.2M
|
|
11/02/2017 |
4
| Coric Vlad (CEO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 25,828 shares
@ $29.04, valued at
$750k
Sold 23,122 shares
@ $29.96, valued at
$692.7k
Sold 1,050 shares
@ $30.51, valued at
$32k
Sold 25,827 shares
@ $29.04, valued at
$750k
Sold 23,123 shares
@ $29.96, valued at
$692.8k
Sold 1,050 shares
@ $30.51, valued at
$32k
Sold 18,074 shares
@ $29.1, valued at
$526k
Sold 6,926 shares
@ $29.62, valued at
$205.1k
Sold 18,074 shares
@ $29.1, valued at
$526k
Sold 6,926 shares
@ $29.62, valued at
$205.1k
|
|
|
|